PSORIASIS: STATE OF THE ART 2013

REFERENCES

• Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol 2012; 26 Suppl 2:3–11.
   PubMed Web of Science ®Google Scholar
• Lehners-Weber Ch, de la Brassinne M, Dézfoulian B, Richert B, Bonardeaux Ch, Willemaers V. Congenital psoriasis following the lines of Blaschko. Ped Dermatol 1996; 13: 219–221.
   Web of Science ®Google Scholar
• Holubar K. Psoriasis - 100 years ago. Dermatologica 1990; 180: 1–4.
   Google Scholar
• Rausin A, Henno A, de la Brassinne M. Biological agents in the treatment of psoriasis. G Rat Dermatol Venereol 2005; 140: 557–560.
   Google Scholar
• Ryan C, Abramson A, Patel M, Menter A. Current investigational drugs in pso-riasis. Expert Opin Investig Drugs 2012; 21: 473–487.
   PubMed Web of Science ®Google Scholar
• Green A. Australian aborigenes and psoriasis. Australasian J Dermatol 1984; 25: 18–24.
   Google Scholar
• Kavli G, Stenvold SE, Vanbakk O. Low prevalence of psoriasis in Norvegian Lapps. Acta Dermato-Venereologica 1985; 65: 262–263.
   PubMed Web of Science ®Google Scholar
• Farber EM, Nall ML. Epidemiology of psoriasis. In: Roenigk and Maibach, Eds: Psoriasis. Marcel Dekker, New-York, 1985.
   Google Scholar
• Lomholt G. Environment, and genetics in psoriasis. In: Farber EM and Cox. Eds. Proceedings of an International Symposium on Psoriasis, pp 21–24. Stanford Uni-versity Press, Stanford 1971.
   Google Scholar
• Bell L, Sedlack R, Beard C. Incidence of psoriasis in Rochester, Minn 1980-1983. Arch Dermatol 1991; 127: 1184–1187.
   PubMed Web of Science ®Google Scholar
• Lambert J, Assal Dowlatshahi E, de la Brassinne M, Nijsten T. A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients results of a Belgian cross sectional study (BELPSO). Eur J Dermatol 2011 doi: 10.1684/ ejd.2011.1623.
   Google Scholar
• Henseler T, Christophers E. Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450–456.
   PubMed Web of Science ®Google Scholar
• Kwon HH, Kwon IH, Youn JI. Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype? Int J Dermatol 2012;51: 53–58.
   PubMed Web of Science ®Google Scholar
• Hebert HL, Ali FR, Bowes J, Griffiths CE, Barton A, Warren RB. Genetic suscepti-bility to psoriasis and psoriatic arthritis: implications for therapy. Br J Dermatol 2012; 166: 474–482.
   PubMed Web of Science ®Google Scholar
• Zhang P. Su Y, Lu Q. Epigenetics and psoriasis. J Eur Acad Derm Venereol 2012; 26: 399–403.
   Web of Science ®Google Scholar
• de la Brassinne M. Le point sur le psoriasis. Rev Med Liege 1983; 38: 294–301.
   Google Scholar
• Oka A, Mabuchi T, Ozawa A, Inoko H. Current understanding of human genetics and genetic analysis of psoriasis. J Dermatol 2012; 39: 231–241.
   Web of Science ®Google Scholar
• Lee JC, Parkes M. 100 Genes for IBD ... Whatever next. Inflamm Bowel Dis Monit 2011; 11: 103–111.
   Google Scholar
• de la Brassinne M, Franchimont C, Sarto D, Bouillenne C. HLA antigens and types of psoriasis. In: Farber EM, Cox AJ, Nall L, Jacobs PH. Eds: Psoriasis. Grune & Stratton, Inc., New-York 1982, pp 285–286.
   Google Scholar
• Mallon E, Newson R, Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: a meta-analysis of published serologic studies. J Invest Dermatol 1999; 113:693–695.
   PubMed Web of Science ®Google Scholar
• Mier PD, van de Kerkhof PCM. Textbook of psoriasis. 292 pp. Churchill Living-stone, Edinburgh 1986.
   Google Scholar
• Henno A, Rausin A, Malaise M, de la Brassinne M. Psoriasis et arthrite psoria-sique. Rev Med Liege 2006; 61: 334–340.
   Google Scholar
• Van de Kerkhof PCM. Textbook of psoriasis. Second Edition 348 pp. Blackwell Publishing, Oxford, 2003.
   Google Scholar
• Tsunemi Y, Saeki H, Nakamura K, et al. Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 2002; 30: 161–166.
   PubMed Web of Science ®Google Scholar
• de la Brassinne M, Dézfoulian B. Role of superantigens in dermatology. In Mallia and Uitto. Rheumaderm 245–248. Kluwer Academic/Plenum Publishers, New-York 1999.
   Google Scholar
• Failla V, Nikkels-Tassoudji N, Sabatiello M, de Schaetzen V, Nikkels A.F. Child-hood herpes zoster triggered guttate psoriasis. Open J Dermatol 2012; 6: 9–12. DOI: 10.2174/1874372201206010009.
   Google Scholar
• de la Brassinne M, Houziaux MO, Bartholome M, Bianchi AR. Conversational computer assisted anamnesis in the management of psoriasis. In: Farber EM, Cox AJ, Nall L, Jacobs PH Eds: Psoriasis. Grune & Stratton, Inc., New-York 1982, pp 361–362.
   Google Scholar
• de la Brassinne M, Neys Ch. Le psoriasis en tant que phénomène psychosoma-tique. Acta Psychiatrica Belgica 1986; 86: 36–41.
   Google Scholar
• de la Brassinne M, Sarto D. Approche psychosomatique du psoriasis. Nouvelles Dermatologiques 1995; 14:300–303.
   Google Scholar
• Sarto D, Fontaine O, de la Brassinne M. Approche psychosomatique du psoriasis (2nd part). Nouvelles Dermatologiques 1996; 15: 628–630.
   Google Scholar
• Hayes J, Koo J. Psoriasis: depression, anxiety, smoking and drinking habits. Der-matol Ther 2010; 23:174–180.
   Google Scholar
• Wolf R, Wolf D, Ruocco V. Alcohol intake and psoriasis. Clin Dermatol 1999; 17: 423–430.
   PubMed Web of Science ®Google Scholar
• Puig L Obesity and psoriasis: body weight and body mass index influence the response to biological treatment. J Eur Acad Dermatol Venereol 2011; 25: 1007–1009.
   PubMed Web of Science ®Google Scholar
• Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Der-matol 1995; 32: 982–986.
   Web of Science ®Google Scholar
• Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban native Swedes. Dermatologica 1986; 172: 298–304.
   PubMedGoogle Scholar
• Maradit-Kremers H, Icen M, Ernste FC, Dierkhising RA, McEvoy MT. Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a popula-tion-based cohort study. J Eur Acad Dermatol Venereol 2012; 26: 336–343.
   Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216.
   PubMed Web of Science ®Google Scholar
• Nijsten T, Unaeze J, Stern RS. Refinement and reduction of the Impact Psoriasis Questionnaire: classical test theory vs. Rasch analysis. Br J Dermatol 2006; 154: 692–700.
   PubMed Web of Science ®Google Scholar
• Ljosaa TM, Mork C, Stubhaug A, Moum T, Wahl AK. Skin pain and skin discom-fort is associated with quality of life in patients with psoriasis. J Eur Acad Derma-tol Venereol 2012; 26: 29–35.
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Azfar RS, Mehta NN. Psoriasis and cardiovascular risk: strenght in numbers. J Invest Dermatol 2010; 130: 919–922.
   PubMed Web of Science ®Google Scholar
• Stern RS. Psoriasis is not a useful independant risk factor for cardiovascular dis-ease. J Invest Dermatol 2010; 130:917–919.
   PubMed Web of Science ®Google Scholar
• Fortune DG, Richards HL, Main CJ, Griffiths CE. Patients strategies for coping with psoriasis. Clin Exp Dermatol 2002; 27: 177–184.
   PubMed Web of Science ®Google Scholar
• Coimbra S, Figueiredo A, Castro E, Rocha-Pereira P. Santos-Silva A. The roles of cells and cytokines in the pathogenesis of psoriasis. Int J Dermatol 2012; 51: 389–395.
   PubMed Web of Science ®Google Scholar
• Henno A, Lapière ChM, Nusgens B, de la Brassinne M. Le système vasculaire lymphatique: états des connaissances et implications dermatologiques potentiel les. Ann Dermatol Vénéréol 2008; 135: 704–709.
   Web of Science ®Google Scholar
• Jablonska S. Majewski. Immunologie du psoriasis. In: de la Brassinne, Roelandts et Bovy (Edts): Psoriasis pp. 19–27. Glaxo Dermatological Publications, Mar-cinelle, 1987.
   Google Scholar
• Sweeney CM, Tobin AM, Kirby B. Innate immunity in the pathogenesis of pso-riasis. Arch Dermatol Res 2011; 303: 691–705.
   PubMed Web of Science ®Google Scholar
• Michalak-Stoma A, Pietrzak A, Szepietowski JC, Zalewska-Janowska A, Pasz-kowski T, Chodorowska G. Cytokine network in psoriasis revisited. Eur Cytokine Netw 2011; 22:160–168.
   PubMed Web of Science ®Google Scholar
• Henno A, Blacher S, Lambert Ch, et al. Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chro-nology in psoriasis. J Dermatol Sci 2010; 57: 162–169.
   Web of Science ®Google Scholar
• Flisiak I, Zaniewski P. Rogalska-Taranta M, Chodynicka B. Effect of psoriasis therapy on VEGV and its soluble receptors serum concentrations. J Eur Acad Dermatol Venereol 2012; 26: 302–307.
   PubMed Web of Science ®Google Scholar
• Henno A, Lapière Ch.M, de la Brassinne M, Nusgens B. The expression of angiogenesis and lymphoangiogenesis markers is higher in normal skin of pso-riatic patients than in healthy volunteer skin. J Invest Dermatol 2006; 126: 99.
   Web of Science ®Google Scholar